Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...

A new unit at the Royal Shrewsbury Hospital will provide improved facilities, increase capacity and help staff diagnose and ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

AngioDynamics, Inc. ( ANGO) Q3 2026 Earnings Call April 2, 2026 8:00 AM EDT Good morning, and welcome to the AngioDynamics Fiscal Year 2026 Third Quarter Earnings Call. [Operator Instructions] As a ...

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2026 Earnings Call Transcript April 2, 2026 AngioDynamics, Inc. misses on earnings ...

Edap Tms S.a. (NASDAQ:EDAP) Q4 2025 Earnings Call Transcript March 25, 2026 Edap Tms S.a. misses on earnings expectations.

Ewing sarcoma (ES) and its variants are rare and aggressive malignancies, occurring in paediatric and younger adult populations. Adamantinoma-like ES (ALES) is one of its variants, characterised by ...

AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment markets. The optimism, led by a solid first-quarter fiscal 2026 performance, ...